Novartis Investigative Site

Yiwu, Zhejiang 322000

0 studies enrolling now · 2 studies all time

What they study most

Chronic Inducible Urticaria, Chronic Spontaneous Urticaria

Studies at this site

• A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines — Running, not enrolling
• A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1-antihistamines — Completed